FDA approves Cochlear Nucleus Implants for unilateral hearing loss/single-sided deafness

/PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of...

Related Keywords

United States ,Anderson Mlet Al ,Graeme Clark ,Kevin Brown ,Christine Menapace ,Otol Neurotol ,Audiol Neurootol ,Clinical Affairs ,Drug Administration ,University Of North Carolina ,Cochlear Limited ,Prnewswire Cochlear Limited ,Children Cochlear Implant Center ,Vice President ,Vice Chair ,Executive Director ,Cochlear Implant Center ,Cochlear Nucleus System ,Cochlear Osia ,Cochlear Baha ,Professor Graeme Clark ,Sided Deafness ,Take Many Forms ,Cochlear Implantation ,Binaural Hearing ,Adults With Unilateral Hearing ,Trends Hear ,Asymmetric Hearing Study ,Prospective Longitudinal Study ,Speech Recognition ,Bear Hear ,Long Term Hearing Outcomes ,Cochlear Implant Users With Single Sided ,Unilateral Hearing Loss ,Initial Localization ,Unilateral Hearing ,Neck Surgery ,